Skip to content

Effect of remimazolam versus propofol on the ventilation of patients undergoing bronchoscopy

Effect of remimazolam versus propofol on the ventilation of patients undergoing bronchoscopy

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200066502
Enrollment
Unknown
Registered
2022-12-07
Start date
2021-11-26
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

respiratory disease

Interventions

Remimazolam group:remimazolam
Propofol group:propofol

Sponsors

Suzhou Dushu Lake Hospital (Dushu Lake Hospital Affiliated to Soochow University)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Aged range from 18 to 70 years, no gender limit; 2. ASA grading ? ~ ?; 3. 18kg/m^2<BMI<30 kg/m^2; 4. In accordance with the "Guidelines for the Application of Diagnostic Bendable Bronchoscopy (2008)" published by the Respiratory Science Branch of the Chinese Medical Association; 5. The operation time of bronchoscopy is expected to be less than 1 hour; 6. Good cough reflex; 7. Clearly understand and voluntarily participate in the study, and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Serious diseases of heart, lung, liver, kidney and other important organs; 2. Had been diagnosed with obstructive sleep apnea; 3. Severe upper airway obstruction; 4. Active massive hemoptysis; 5. Bradycardia (HR<60 beats /min); 6. Allergic to study drugs; 7. People who can't communicate and cooperate.

Design outcomes

Primary

MeasureTime frame
tidal impendence variation;?EELI (? end-expiratory lung impedance);Pulse oxygen saturation (T2);

Secondary

MeasureTime frame
induction time;recovery time;adverse events;

Countries

China

Contacts

Public ContactZhang Lan

Suzhou Dushu Lake Hospital (Dushu Lake Hospital Affiliated to Soochow University)

zhanglan861006@163.com+86 18013146716

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026